

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


Micro Focus Chair Steps Down As Results Fall Short Of Estimates


Pharmaceuticals group Sinclair Pharma said it will raise up to £25m in a share placing to pay for two major dermatology products as it named Christoph...


Sinclair Pharma is slightly higher. The specialty pharma company today announced that it has received an extension on the ability to draw down a furth...


Sinclair Pharma admitted that it is in discussion about a potential "significant" product acquisition after its share price surged. "The company wou...


Pharmaceuticals group Sinclair Pharma has issued convertible unsecured loan notes worth about £2.3m to a leading institutional investor. A first seri...


GlaxoSmithKlein should be a dead cert buy in the current climate. The twin drivers of the recession, which normally favours pharmaceutical companies, ...


Footsie finished with gains for the eighth day in a row to sit just shy of 4,500 points after flitting between the red and the blue for much of the da...


Pharmaceuticals group Sinclair Pharma said it expects annual EBITDA to be in line with board expectations while revenue is expected to decline as whol...


The Footsie briefly moved into positive territory over the lunch time session before easing gently back into the red. Pharmaceuticals giant GlaxoSmit...